BioCryst Pharmaceuticals (NASDAQ:BCRX) Reaches New 12-Month Low at $6.78

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $6.78 and last traded at $6.89, with a volume of 136745 shares trading hands. The stock had previously closed at $6.97. Analyst Ratings Changes Several equities analysts have recently weighed in on BCRX […]

Related Keywords

United States ,America ,Machelle Sanders ,Biocryst Pharmaceuticals ,Advisory Services Network ,News Ratings For Biocryst Pharmaceuticals Daily ,Biocryst Pharmaceuticals Stock Down ,Fairfield Bush ,Needham Company ,Institutional Trading Of Biocryst Pharmaceuticals ,Nasdaq ,Lazard Asset Management ,Securities Exchange Commission ,Biocryst Pharmaceuticals Inc ,Get Free Report ,Cryst Pharmaceuticals Stock Down ,Cryst Pharmaceuticals ,Director Machelle Sanders ,Exchange Commission ,Asset Management ,Services Network ,Biocryst Pharmaceuticals Daily ,Nasdaq Bcrx ,Bcrx ,Medical ,09058v10 ,Stocks ,Technicals ,